glipizide/metformin (Metaglip) (cont.)

Pharmacy Author:
Medical and Pharmacy Editor:

In clinical studies, glipizide/metformin therapy was superior in improving fasting plasma glucose, postprandial plasma glucose (blood glucose levels after a meal), and HbA1c versus treatment with either agent alone.

Glipizide/metformin was approved by the FDA in October 2002.

PRESCRIBED FOR: Glipizide/metformin is used as an adjunct to diet and exercise to improve blood glucose control in adults with type 2 diabetes.

SIDE EFFECTS: The most common side effects associated with glipizide/metformin treatment are:

Side effects related to the stomach were most commonly reported by patients who newly started treatment with glipizide/metformin and included:

Medically Reviewed by a Doctor on 2/5/2015

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.

Back to Medications Index